Concept explainers
Vascular endothelial growth factor receptor 2 (VEGFR-2) is an endothelial cell-specific receptor that has inherent tyrosine kinase activity. The binding of the Vascular endothelial growth factor (VEGF) ligand to its receptor plays an important role in angiogenesis, a process by which new capillaries are formed. Enhanced angiogenesis is associated with a number of diseases including cancer. Your goal is to develop a homogeneous in vitro TR-FRET kinase assay for VEGFR-2 (purified protein) in an attempt to identify small molecules that inhibit kinase activity and in turn modulate angiogenesis.
Based on this background, please answer the following questions
How would you apply a TR-FRET assay to measure the in vitro kinase activity of VEGFR-2? Describe in steps the assay design and potential readout outcome.
Trending nowThis is a popular solution!
Step by stepSolved in 3 steps
- You want to understand how the density of P-selectin in blood vessel walls affects the rolling interactions of neutrophils when they are subjected to hydrodynamic drag forces in the blood. You introduce P-selectin into a synthetic lipid bilayer and attach it to a glass slide mounted in a flow chamber. This arrangement allows you to measure neutrophil attachment at different densities of P-selectin and at different flow rates. At high densities, from 30 to 400 P-selectin molecules per µm², the neutrophils attached to the membrane and rolled very slowly and jerkily in the direction of the flow (see cell 1 in the figure). At the same flow rate, but at a density of 15 P-selectins per µm², the neutrophils behaved differently: they either moved at the flow rate of the medium or were transiently tethered-horizontal lines marked by t-before moving again (cell 2 in the figure). Neutrophils showed this same behavior at a density of 1 P-selectins per μm² and half the flow rate: moving at the flow…arrow_forwardCystic fibrosis (CF) is a genetic disorder caused by mutations in the CFTR (cystic fibrosis transmembrane-conductance regulator) gene, which encodes the CFTR protein. The cells of the lining of the lungs contain high levels of the CFTR protein in their membranes. Normally, CFTR contains a chloride ion channel, which permits chloride ions to pass from inside the cells to the cells’ surfaces. The surface chloride ions are able to attract water in the lungs, allowing for the formation of a water layer on the cells’ surfaces. This thin water layer is necessary to allow the cilia, the tiny hairs on the surface of the lining cells to move back and forth easily. This motion permits the removal of mucus from the lungs. A particular error in the CFTR gene results in the replacement of the amino acid Phe with Ser at residue 508 of the CFTR protein. Individuals afflicted with CF most often experience the presence of thick, dry and sticky mucus in the lungs, leading to chronic infections and…arrow_forwardRho activation is preceded by association of a Rho regulator to regions of the plasma membrane just “above” where the contractile ring will form. Which regulator (Rho GAP or Rho GEF) would you predict would be localized to this region of the cell? Briefly explain your reasoning.arrow_forward
- One form of anemia results when individuals have a deficiency in the enzyme phosphatidylinositol glycan A (PIGA). This enzyme is required for the membrane attachment of proteins anchored by glycolipids to the plasma membrane, using what is called a ‘GPI-linkage.’ Included in the group of GPI-linked cell surface proteins is DAF/CD55. These individuals become anemic because: DAF/CD55 prevents the lysis of red blood cells by infecting pathogens. DAF/CD55 normally prevents the spleen from clearing healthy red blood cells from the circulation. In the absence of PIGA, the red blood cell membrane is bare of proteins allowing increased access of complement activating proteins to attach to the cell membrane. DAF/CD55 is a complement inhibitory protein that inactivates any C3 convertase that may form on host cell surfaces. In the absence of PIGA, red blood cells are unable to synthesize high levels of hemoglobin.arrow_forwardOne medication used in treating COVID patients who have been placed on mechanical ventilators is Vecuronium, an acetylchone antagonist at skeletal muscle neuromuscular junctions (NMJs). Vecuronium is used on sedated patients to provide skeletal muscle paralysis, which allows the mechanical ventilator to work without the patient’s diaphragm contracting on its own and potentially working against the ventilator. Please do two things: Explain the way in which the NMJ would cause skeletal muscle contraction in the absence of the medication. Start by describing the mechanism of neurotransmitter release in the presynaptic cell and stop when the first crossbridge cycle is complete. Explain the specific way in which the medication impacts the functionality of the NMJ and skeletal muscle contraction. Please make sure to include 1.NT release 2.AP 3.Calcium release/binding 4.Crossbridge cycling 5.Med impactarrow_forwardThe egfr kinase independent transactivation of the ras pathway does require egfr. Explain this apparent contradiction.arrow_forward
- You decide to investigate cell signaling of a pair of newly identified GPCRs, GPCR-W and GPCR-Z. Each binds the same ligand, but activates different downstream heterotrimeric G-proteins that act on adenylyl cyclase. You discover that ligand binding has opposite effects on adenylyl cyclase activity for each receptor. GPCR-W causes an increase in adenylyl cyclase activity, while GPCR-Z causes a decrease in adenylyl cyclase activity. You obtain a cell line expressing GPCR-W, GPCR-Z, the relevant G-proteins, and adenylyl cyclase. There is baseline adenylyl cyclase activity producing a baseline amount of cAMP. You embark on a research project to characterize the following mutations in the components of the signaling pathway. 2. Will each of the following mutations increase or decrease the levels of cAMP inside the cell upon adding the ligand to the cell culture? A mutation in Gi that prevents release of bound GDP. A mutation in Gs that prevents GTP hydrolysis. A mutation in Gi that…arrow_forwardType I diabetes is caused by destruction of the beta cells of the pancreas, the cells that produce insulin. In most cases, the beta cells are destroyed by an immune response. Both genetic and environmental factors are involved in triggering the immune response. NOD mice develop a disease very much like Type I diabetes. (NOD mouse = non-obese, diabetic, mouse). If you transfer plasma from a NOD mouse to a normal mouse, the normal is not affected. If you transfer lymphocytes (WBCs white blood cells) from a NOD mouse, the normal mouse develops diabetes. The first people to figure this out found they had to transfer two types of WBC to transfer diabetes. After some experiments, they found that under the right conditions, they only had to transfer one type of cell to cause diabetes in the recipient. B-1. Consider the one type of WBC that can cause diabetes by itself. Which type is it likely to be? (B cells) (helper T cells) (cytotoxic T cells) (either type of T cell) (any of these)…arrow_forwardA fixed amount of radiolabelled insulin was incubated with a fixed amount of anti-insulin antibody, the bound ligand was separated from free ligand at different time intervals. Draw a diagram of the concentration of the insulin/antibody complex with time. (Insulin/antibody complex is the bound ligand) asap typed only .arrow_forward
- i found this past paper however i cannot find the solutions, please can you answer question 1carrow_forwardYou have made several mutations in the coding region of the gene coding for the sodium channel and placed them in expression vectors to have the synthetic proteins placed in the membranes of the cultured cells. As a result, the cells no longer contract with the same force as the wild type. why does this occur?arrow_forwardExplain how GEF and GAP activate and deactivate RAS, respectively.arrow_forward
- Human Anatomy & Physiology (11th Edition)BiologyISBN:9780134580999Author:Elaine N. Marieb, Katja N. HoehnPublisher:PEARSONBiology 2eBiologyISBN:9781947172517Author:Matthew Douglas, Jung Choi, Mary Ann ClarkPublisher:OpenStaxAnatomy & PhysiologyBiologyISBN:9781259398629Author:McKinley, Michael P., O'loughlin, Valerie Dean, Bidle, Theresa StouterPublisher:Mcgraw Hill Education,
- Molecular Biology of the Cell (Sixth Edition)BiologyISBN:9780815344322Author:Bruce Alberts, Alexander D. Johnson, Julian Lewis, David Morgan, Martin Raff, Keith Roberts, Peter WalterPublisher:W. W. Norton & CompanyLaboratory Manual For Human Anatomy & PhysiologyBiologyISBN:9781260159363Author:Martin, Terry R., Prentice-craver, CynthiaPublisher:McGraw-Hill Publishing Co.Inquiry Into Life (16th Edition)BiologyISBN:9781260231700Author:Sylvia S. Mader, Michael WindelspechtPublisher:McGraw Hill Education